HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved method for serological testing in celiac disease--IgA anti-endomysium antibody test: a comparison between monkey oesophagus and human umbilical cord as substrate in indirect immunofluorescence test.

Abstract
The IgA anti-endomysium antibody (IgA-EmA) test has been studied using the indirect immunofluorescence (IF) method with human umbilical cord (HUC) as substrate; 247 sera from patients investigated for celiac disease were tested. The results were in accordance with those obtained using monkey oesophagus (MOE) as substrate. IgA-EmA testing using HUC is shown to have similar reproducibility, sensitivity and specificity as MOE. By avoiding both fixation in chloroform and the blocking step, the processing time for this improved method is decreased by almost 1 h, and the results are stable for reading by fluorescence microscopy for at least 24 h. The indirect IF method using HUC as substrate is easy, reliable and inexpensive. We conclude that the IgA-EmA test using HUC as a substrate can be routinely used for celiac disease screening and follow up.
AuthorsW Amara, A Husebekk
JournalScandinavian journal of clinical and laboratory investigation (Scand J Clin Lab Invest) Vol. 58 Issue 7 Pg. 547-54 (Nov 1998) ISSN: 0036-5513 [Print] England
PMID9890337 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • ABO Blood-Group System
  • Autoantibodies
  • Immunoglobulin A
Topics
  • ABO Blood-Group System
  • Animals
  • Autoantibodies (blood)
  • Celiac Disease (blood, diagnosis, immunology)
  • Esophagus
  • Fluorescent Antibody Technique, Indirect (statistics & numerical data)
  • Haplorhini
  • Humans
  • Immunoglobulin A (blood)
  • In Vitro Techniques
  • Muscle Fibers, Skeletal (immunology)
  • Reproducibility of Results
  • Umbilical Cord

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: